Free Trial
NASDAQ:COCP

Cocrystal Pharma (COCP) Stock Price, News & Analysis

Cocrystal Pharma logo
$1.58 +0.02 (+0.96%)
As of 09:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cocrystal Pharma Stock (NASDAQ:COCP)

Key Stats

Today's Range
$1.56
$1.60
50-Day Range
$1.41
$1.70
52-Week Range
$1.12
$3.26
Volume
2,389 shs
Average Volume
26,316 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Cocrystal Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

COCP MarketRank™: 

Cocrystal Pharma scored higher than 51% of companies evaluated by MarketBeat, and ranked 550th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cocrystal Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cocrystal Pharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cocrystal Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for Cocrystal Pharma are expected to decrease in the coming year, from ($1.85) to ($2.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cocrystal Pharma is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cocrystal Pharma is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cocrystal Pharma has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cocrystal Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    0.07% of the float of Cocrystal Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Cocrystal Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cocrystal Pharma has recently decreased by 64.96%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cocrystal Pharma does not currently pay a dividend.

  • Dividend Growth

    Cocrystal Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the float of Cocrystal Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Cocrystal Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cocrystal Pharma has recently decreased by 64.96%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cocrystal Pharma this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for COCP on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Cocrystal Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cocrystal Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    28.14% of the stock of Cocrystal Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 6.72% of the stock of Cocrystal Pharma is held by institutions.

  • Read more about Cocrystal Pharma's insider trading history.
Receive COCP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cocrystal Pharma and its competitors with MarketBeat's FREE daily newsletter.

COCP Stock News Headlines

Cocrystal Pharma Holds 2025 Annual Stockholders Meeting
BofA: Is this the next SpaceX?
Everyone is focusing on AI stocks... Yet little-known "space stocks" are rocketing to record highs with gains of 588% - 3,710%! One new space stock that I call "the next SpaceX" is preparing to IPO on the NASDAQ. Right now, you can grab Pre-IPO shares for less than $4.00. And my estimates suggest the valuation could soar 457% with the IPO. Get urgent details inside this free report...
See More Headlines

COCP Stock Analysis - Frequently Asked Questions

Cocrystal Pharma's stock was trading at $2.02 at the beginning of the year. Since then, COCP stock has decreased by 21.5% and is now trading at $1.5850.

Cocrystal Pharma, Inc. (NASDAQ:COCP) announced its earnings results on Thursday, May, 15th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.52) by $0.29.

Shares of Cocrystal Pharma reverse split on Tuesday, October 11th 2022.The 1-12 reverse split was announced on Tuesday, October 11th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of COCP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cocrystal Pharma investors own include NVIDIA (NVDA), Meta Platforms (META), OPKO Health (OPK), Advanced Micro Devices (AMD), NIO (NIO), CrowdStrike (CRWD) and Pfizer (PFE).

Company Calendar

Last Earnings
5/15/2025
Today
7/10/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:COCP
CIK
1412486
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+284.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.50 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-135.12%
Return on Assets
-102.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.57
Quick Ratio
4.57

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.94 per share
Price / Book
1.66

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
2.07
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:COCP) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners